Characterizing the cancer genome in lung adenocarcinoma.
about
arrayMap: a reference resource for genomic copy number imbalances in human malignanciesNew strategies and emerging technologies for massively parallel sequencing: applications in medical researchUpdate in lung cancer 2007MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasisKras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lungNKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferationFunctional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancerNIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressorIs NF-kappaB a good target for cancer therapy? Hopes and pitfallsCaSNP: a database for interrogating copy number alterations of cancer genome from SNP array dataComprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomesGenomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancerMolecular biology of lung cancer: clinical implicationsLung cancer signatures in plasma based on proteome profiling of mouse tumor modelsComplex landscapes of somatic rearrangement in human breast cancer genomes.MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibSomatic mutations affect key pathways in lung adenocarcinomaIntegrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancersTranscriptome sequencing to detect gene fusions in cancerGene aberrations for precision medicine against lung adenocarcinomaCancer Bioinformatic Methods to Infer Meaningful Data From Small-Size CohortsIdentifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancerBenign Hereditary Chorea: An UpdateResearch progress of thyroid transcription factor-1 as molecular marker in lung carcinomaFrom modules to medicine: How modular domains and their associated networks can enable personalized medicineGenomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studiesGenetic characteristics and research progress of targeted therapy in squamous cell carcinomaNkx2-1: a novel tumor biomarker of lung cancerOne mouse, one patient paradigm: New avatars of personalized cancer therapyEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesProteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancerHomeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.A role for E2F activities in determining the fate of Myc-induced lymphomagenesisStructural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung CancerClinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma
P2860
Q21134582-15645898-B5DA-4C98-8E3E-FC9C3D72E64BQ21183966-523D5616-C3D9-44A3-BA22-3E2B1E9D805EQ22241904-B75BB183-3BD2-449E-A01D-FCB7427AB952Q24297454-E8B57D03-BD5D-43AB-B6FA-852D43629A62Q24303485-2BCB3F21-A1EC-4674-809C-393041D523F9Q24317081-E0280F6C-820E-4225-8583-5C5242CD7AFBQ24338701-77573C61-A115-4075-B33A-0D59B084F89EQ24338837-49072B63-DEF2-4E76-9A13-2FB82A18D964Q24570128-0F8B806E-D01C-4394-A8B5-D3BA11A38BB1Q24607064-BD847F3B-6DA9-48C9-BE70-9FBDFC929D50Q24607126-5339EF14-0514-420F-A6BF-7A3B55575841Q24610167-D0B74903-6AA9-4B62-A14A-2FD8AE8AAEE2Q24610335-4226E6A1-5F15-4141-BB92-D252C2595472Q24628852-5CC3BE7F-59B0-4D5C-9328-8B398FD43630Q24631412-F921E269-6E9A-49C0-9917-79B727C97240Q24646295-67720E95-A09D-4B81-923F-73C287BF3379Q24648102-9662D198-C257-47B4-99B3-69EEBD0B6456Q24649562-2530F74B-7E56-49F3-9D5F-80B0785105B7Q24653386-488574AE-CFD4-4E9C-A7BE-0DD36F8E7E99Q26749348-4DE8C95A-C642-4421-8583-911C05FCB30CQ26777117-E0341391-4613-427F-8229-D38CB306C448Q26781810-A67168A1-DAAE-4BE0-BB38-DE57AA4E22F0Q26801431-7482FAA9-CA95-4F7C-B499-4C3DFF2F78B2Q26826821-503131B4-74A1-43B5-99ED-A5C5E4DABD3AQ26830811-29620245-B93B-41CA-B523-212C48FE3B04Q26851787-B9BF0796-A777-4585-835B-B539FC790288Q26865529-36F6E8C9-8FFE-45E2-ACEE-49EED9F5AD7CQ26995181-A4178241-4A1E-4DB7-ACBC-C08793342215Q27023342-41D11C4A-0B03-4397-A931-D98BF46DD028Q27023830-DEF74453-7695-486C-99D5-9FDEB96141A1Q27307731-F867FAEA-80F0-46A2-ACE7-D75B6D99C504Q27312570-FDE57B2E-BE43-4DD0-85EC-9DB9811F5543Q27349135-5CC6D344-66EA-420D-9CA4-545E31D5B2EAQ27680966-105E04CB-B195-47FC-81AF-B2B0DF15C2ADQ27851458-A1AC1F93-5475-44DA-9018-9C8F90979062Q27851543-2BC9BC1C-3B48-481C-BE4D-907FD87097A5Q27851615-7EE2BF28-6202-425D-A067-40567A97F7A2Q27851654-29F0319B-3BFE-4A2C-A6DF-87B401631D76Q27851728-A218773B-C1E7-43B4-A1B9-0553EBF4B838Q27852873-477AF1DB-599D-4F44-8A5D-5DFA27FE2F90
P2860
Characterizing the cancer genome in lung adenocarcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Characterizing the cancer genome in lung adenocarcinoma
@nl
Characterizing the cancer genome in lung adenocarcinoma.
@ast
Characterizing the cancer genome in lung adenocarcinoma.
@en
type
label
Characterizing the cancer genome in lung adenocarcinoma
@nl
Characterizing the cancer genome in lung adenocarcinoma.
@ast
Characterizing the cancer genome in lung adenocarcinoma.
@en
altLabel
Characterizing the cancer genome in lung adenocarcinoma
@en
prefLabel
Characterizing the cancer genome in lung adenocarcinoma
@nl
Characterizing the cancer genome in lung adenocarcinoma.
@ast
Characterizing the cancer genome in lung adenocarcinoma.
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Characterizing the cancer genome in lung adenocarcinoma.
@en
P2093
Adi F Gazdar
Akihiko Yoshizawa
Aldi Kraja
Alex H Ramos
Barbara A Weir
Bruce E Johnson
David A Wheeler
David G Beer
David Twomey
Derek Y Chiang
P2860
P2888
P304
P3181
P356
10.1038/NATURE06358
P407
P50
P577
2007-11-04T00:00:00Z
P5875
P6179
1019681472